Your practice submitted the prior auth. The payer denied it. Your billing coordinator spent an hour writing an appeal letter. The payer denied that too.
This is not bad luck. It is a pattern, and it is almost never about the clinical merits of the case.
Federal data shows that when prior auth denials are appealed, most are overturned. If your appeals are not winning at that rate, the problem is not your patients or your physicians. The problem is in how the appeal is being constructed.
Sources: KFF analysis of Medicare Advantage prior authorization data, as reported by the AMA; AMA 2024 Prior Authorization Physician Survey (1,000 physicians, late 2024).
Here are the five reasons prior auth appeals fail, and what to do about each one.
Reason 1: Your Appeal Letter Does Not Reference the Payer's Own Criteria
This is the single most common reason appeals fail, and it is entirely preventable.
Every major payer (Aetna, UnitedHealthcare, Cigna, Humana, BCBS) publishes Clinical Policy Bulletins (CPBs) or Coverage Determination Guidelines that define exactly what criteria must be met for a procedure or medication to be approved. These documents are publicly available on every payer's provider website.
Most appeal letters ignore them entirely.
Instead of citing the payer's own criteria, most practices write generic clinical justification: a paragraph explaining why the patient needs the medication. Insurance reviewers are not reading for clinical eloquence. They are checking boxes against a specific document. If your appeal does not speak to that document directly, it fails regardless of how compelling the clinical argument is.
What to do instead:
- Pull the payer's CPB for the specific procedure or medication before writing a single word of the appeal
- Identify which criteria the denial letter claims were not met
- Address each criterion specifically, by name, with clinical evidence from the patient's record
- Quote the payer's own language back to them
An appeal that says "Per Aetna Clinical Policy Bulletin 0282, coverage requires documented failure of two conventional DMARDs prior to biologic therapy initiation. The attached records demonstrate trial and failure of methotrexate (12 months, discontinued due to hepatotoxicity) and hydroxychloroquine (8 months, inadequate response documented 3/15/2026)" gets read differently than one that says "This patient requires this medication because their condition is severe."
Reason 2: “Medical Necessity Not Established” Is Vague, and Your Appeal Is Too
What it means: “Medical necessity not established” means the payer’s reviewer did not find documentation that meets one or more of that payer’s coverage criteria for the service. The letter rarely says which criterion, so your first job is to find out.
When a payer sends back a denial that says "medical necessity not established," they have told you almost nothing useful. Medicare Advantage plans alone denied 4.1 million prior authorization requests in full or in part in 2024, according to KFF, and vague reasons like this one are routine on those letters. The phrase is designed to be non-specific.
Most practices respond with an equally vague appeal. They send more clinical notes, a letter from the physician, maybe a journal article. The reviewer reads it, checks their criteria sheet, finds nothing that directly addresses the unstated gap, and denies again.
The real reason behind "medical necessity not established" is almost always one of four things:
| What the denial letter says | What it usually means |
|---|---|
| Medical necessity not established | A specific documentation element is missing |
| Not medically necessary for this indication | The submitted diagnosis code does not match the approved indication |
| Criteria not met | Step therapy requirements are not documented |
| Insufficient clinical information | The record submitted did not include a required element |
What to do instead:
Before writing your appeal, call the payer's provider line and ask specifically: "Which criteria were not met and what documentation would be needed to satisfy them?" For most plans, the payer has to tell you. Since January 2026, Medicare Advantage plans, Medicaid and CHIP programs, and plans sold on the federal Marketplace must give a specific reason for any denied prior authorization (CMS rule CMS-0057-F; prescription drugs are excluded). Employer health plans covered by ERISA must state the specific reason and the plan rule or guideline they relied on. Get the actual reason in writing before you spend time on an appeal that targets the wrong gap.
Reason 3: You Missed the Appeal Window
This one is not about appeal quality. It is about math.
Miss the deadline and the revenue is gone. Permanently. No matter how strong the appeal would have been.
What most practices do not realize is that appeal deadlines vary significantly by payer, plan type, and appeal level, and the clock starts the moment the denial is issued, not the moment your billing coordinator discovers it buried in a stack of mail.
| Appeal Level | Typical Window |
|---|---|
| Level 1 Internal Appeal | 30 to 180 days from denial date |
| Level 2 Internal Appeal | 60 days from Level 1 denial |
| External Review | 4 months from final internal denial |
| Medicare Advantage | 60 days from denial notice |
| Medicaid | Varies by state, often 30 to 90 days |
The compounding problem
A denial that arrives on a Tuesday and sits in an inbox for two weeks has already consumed a significant portion of its appeal window. A denial that gets routed to the wrong person, or flagged for follow-up and forgotten, may already be past deadline by the time anyone acts on it.
Most practices have no system that automatically surfaces a denial the moment it arrives and counts down the remaining window in real time. That absence, not clinical weakness, is what causes deadlines to lapse.
Reason 4: The Appeal Is Being Filed at the Wrong Level
Not all appeals are equal. Most practices file Level 1 internal appeals and stop there when they are denied. They do not know that Level 2 internal appeals exist, that external review is available, or that peer-to-peer review (a direct physician-to-physician call with the payer's medical director) can reverse a denial before a formal appeal is ever filed.
The appeal escalation ladder looks like this:
- Denial
- Level 1 Internal Appeal: to the payer's internal review team
- Level 2 Internal Appeal: to the payer's senior review committee
- External Independent Review: an independent third-party reviewer
- Peer-to-Peer Review: your physician speaks directly with the payer's medical director
- State Insurance Commissioner Complaint
- Legal Action
Most practices never get past Level 1. High-performing practices know that the further up the escalation ladder a case goes, the better their odds typically become, because the reviewers at each level are more senior, more accountable, and more likely to read the clinical record carefully.
What to do instead:
Build a triage system that classifies every denial by dollar value of the claim, likelihood of overturn based on denial reason, and escalation level most appropriate given the denial type.
High-value denials with clear documentation gaps go straight to Level 1 internal appeal with a complete clinical record. Denials that survive Level 1 should automatically trigger a Level 2 filing. Any denial involving a biologic or high-cost medication should be flagged for peer-to-peer review consideration before the window closes.
Reason 5: You Are Appealing With the Same Documentation That Got Denied
If your first submission was denied because it lacked a specific element, filing an appeal with the same documentation package guarantees the same result.
This sounds obvious. In practice it happens constantly, because the billing coordinator filing the appeal is not the same person as the physician who documented the case, and the communication gap between them means the appeal goes out before anyone has verified that the missing element is now present.
The five documentation gaps that cause the most denials in high-PA specialties:
| Specialty | Most Common Missing Element |
|---|---|
| Rheumatology | Documented failure of conventional DMARDs before biologic initiation |
| Dermatology | Documented trial and failure of topical corticosteroids |
| Gastroenterology | Documented failure of conventional therapy before biologic |
| Endocrinology | Prior medication history and contraindication documentation for GLP-1s |
| Neurology | Disease severity scores and prior treatment history |
What to do instead:
Before filing any appeal, run a pre-appeal checklist against the payer's specific CPB criteria for that medication or procedure. Identify every element required. Confirm that each one is present in the documentation being submitted. Only then file.
This adds 15 minutes to the appeal process. It dramatically increases the overturn rate.
The Pattern Underneath All Five Reasons
Look at the five reasons above and notice what they have in common.
None of them are about clinical quality. Your physicians are making good clinical decisions. Your patients genuinely need these medications and procedures.
Every single failure point is administrative:
- Not knowing the payer's criteria
- Not getting the specific denial reason
- Missing the deadline
- Not escalating to the right level
- Not verifying documentation before filing
"Payers do not win on clinical merit. They win on administrative attrition. The volume of denials is engineered to exceed the bandwidth of your billing team."
The vagueness of denial letters is engineered to make figuring out the real reason take more time than most practices have. The appeal windows are short enough that delays compound into missed deadlines.
The practices that win at prior auth appeals are not the ones with better physicians. They are the ones with better administrative infrastructure.
What Better Infrastructure Looks Like
The difference between a practice that recovers its denials and one that writes them off is rarely staffing. It is systems.
- Real-time denial detection. Every denial surfaces immediately, not when someone checks the portal, not when the paper letter arrives. The moment a denial is issued, the clock starts and the right person is notified.
- Payer-specific appeal generation. Appeal letters that automatically reference the payer's own CPB language for the specific medication or procedure being appealed, not generic clinical arguments.
- Deadline tracking. Every open denial visible with the hours remaining on the appeal window, ranked by urgency. No deadline closes silently.
- Escalation prompts. When a Level 1 appeal is denied, the system flags Level 2 and peer-to-peer review windows before they close.
- Disposition tracking. Every denial outcome recorded: appealed and won, appealed and lost, written off, medication switched. Over time this data reveals which payers, which denial reasons, and which medications are most recoverable, and the appeal language that wins most often.
The Revenue Reality
In Medicare Advantage, only about 1 in 10 prior auth denials is appealed, and more than 8 in 10 of those appeals succeed. Most unappealed denials are not clinical losses. They are administrative ones: denials that expired without a fight because the practice did not have the infrastructure to fight back.
If your practice is writing off prior auth denials because there is not enough time or bandwidth to appeal every one, the question is not whether you can afford to fix that. The question is how much longer you can afford not to.